Molecular Mechanisms of Immune Escape for Foot-and-Mouth Disease Virus
Abstract
:1. Introduction
2. Molecular Mechanisms in FMDV Structural Protein Immune Escape
2.1. VP0
2.2. VP4
2.3. VP2
2.4. VP1
2.5. VP3
3. Molecular Mechanisms in FMDV Non-Structural Protein Immune Escape
3.1. Lpro
3.2. 2B
3.3. 2C
3.4. 3A
3.5. 3B
3.6. 3C
4. Molecular Mechanisms for FMDV Untranslated Region in Immune Escape
4.1. 5′ UTR
4.2. 3′ UTR
5. Prospects and Future Directions
6. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Alexandersen, S.; Mowat, N. Foot-and-mouth disease: Host range and pathogenesis. In Foot and Mouth Disease Virus; Mahy, B.W.J., Ed.; Springer Science and Business Media LLC: Berlin, Germany, 2005; Volume 288, pp. 9–42. [Google Scholar]
- Grubman, M.J.; Baxt, B. Foot-and-mouth disease. Clin. Microbiol. Rev. 2004, 17, 465–493. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jamal, S.M.; Belsham, G.J. Foot-and-mouth disease: Past, present and future. Veter. Res. 2013, 44, 116. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Knowles, N.J.; Samuel, A.R. Molecular epidemiology of foot-and-mouth disease virus. Virus Res. 2003, 91, 65–80. [Google Scholar] [CrossRef]
- Haydon, D.; Samuel, A.; Knowles, N. The generation and persistence of genetic variation in foot-and-mouth disease virus. Prev. Veter. Med. 2001, 51, 111–124. [Google Scholar] [CrossRef]
- Domingo, E.; Pariente, N.; Airaksinen, A.; González-Lopez, C.; Sierra, S.; Herrera, M.; Grande-Pérez, A.; Lowenstein, P.R.; Manrubia, S.C.; Lázaro, E.; et al. Foot-and-mouth disease virus evolution: Exploring pathways towards virus extinction. In Foot and Mouth Disease Virus; Mahy, B.W.J., Ed.; Springer Science and Business Media LLC: Berlin, Germany, 2005; Volume 288, pp. 149–173. [Google Scholar]
- Domingo, E.; Ruiz-Jarabo, C.M.; Sierra, S.; Arias, A.; Pariente, N.; Baranowski, E.; Escarmis, C. Emergence and selection of RNA virus variants: Memory and extinction. Virus Res. 2002, 82, 39–44. [Google Scholar] [CrossRef]
- Klein, J. Understanding the molecular epidemiology of foot-and-mouth-disease virus. Infect. Genet. Evol. 2009, 9, 153–161. [Google Scholar] [CrossRef]
- Mason, P.W.; Grubman, M.J.; Baxt, B. Molecular basis of pathogenesis of FMDV. Virus Res. 2003, 91, 9–32. [Google Scholar] [CrossRef]
- Vossen, M.T.; Westerhout, E.M.; Söderberg-Naucler, C.; Wiertz, E.J.H.J. Viral immune evasion: A masterpiece of evolution. Immunogenetics 2002, 54, 527–542. [Google Scholar] [CrossRef]
- Golde, W.T.; Nfon, C.K.; Toka, F.N. Immune evasion during foot-and-mouth disease virus infection of swine. Immunol. Rev. 2008, 225, 85–95. [Google Scholar] [CrossRef]
- Li, X.; Wang, J.; Liu, J.; Li, Z.; Wang, Y.; Xue, Y.; Li, X.; Cao, H.; Zheng, S.J. Engagement of soluble resistance-related calcium binding protein (sorcin) with foot-and-mouth disease virus (FMDV) VP1 inhibits type I interferon response in cells. Veter. Microbiol. 2013, 166, 35–46. [Google Scholar] [CrossRef]
- Medina, G.N.; Knudsen, G.M.; Greninger, A.L.; Kloc, A.; Segundo, F.D.-S.; Rieder, E.; Grubman, M.J.; DeRisi, J.L.; Santos, T.D.L. Interaction between FMDV Lpro and transcription factor ADNP is required for optimal viral replication. Virology 2017, 505, 12–22. [Google Scholar] [CrossRef] [PubMed]
- Fu, S.Z.; Yang, W.P.; Ru, Y.; Zhang, K.S.; Wang, Y.; Liu, X.T.; Li, D.; Zheng, H. DDX56 cooperates with FMDV 3A to enhance FMDV replication by inhibiting the phosphorylation of IRF3. Cell. Signal. 2019, 64, 109393. [Google Scholar] [CrossRef] [PubMed]
- Sabbah, A.; Chang, T.H.; Harnack, R.; Frohlich, V.; Tominaga, K.; Dube, P.H.; Xiang, Y.; Bose, S. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 2009, 10, 1073–1080. [Google Scholar] [CrossRef] [PubMed]
- Liu, H.; Zhu, Z.; Xue, Q.; Yang, F.; Cao, W.; Zhang, K.; Liu, X.; Zheng, H. Foot-and-mouth disease virus antagonizes NOD2-mediated antiviral effects by inhibiting NOD2 protein expression. J. Virol. 2019, 93, 93. [Google Scholar] [CrossRef] [Green Version]
- Fry, E.E.; Stuart, D.I.; Rowlands, D.J. The structure of foot-and-mouth disease virus. Curr. Top. Microbiol. Immunol. 2005, 288, 71–101. [Google Scholar] [PubMed]
- Mou, H.; Ma, X.; Luo, Z.; Zhang, J.; Zheng, H.X. Structural protein VP0 of foot-and-mouth disease virus inhibits type I interferon signaling pathway. Weishengwu Xuebao 2017, 57, 994–1003. [Google Scholar]
- Li, D.; Zhang, J.; Yang, W.; He, Y.; Ru, Y.; Fu, S.; Li, L.; Liu, X.; Zheng, H. Poly (rC) binding protein 2 interacts with VP0 and increases the replication of the foot-and-mouth disease virus. Cell Death Dis. 2019, 10, 516. [Google Scholar] [CrossRef] [Green Version]
- You, F.; Sun, H.; Zhou, X.; Sun, W.; Liang, S.; Zhai, Z.; Jiang, Z. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat. Immunol. 2009, 10, 1300–1308. [Google Scholar] [CrossRef]
- Curry, S.; Fry, E.; Blakemore, W.; Abu-Ghazaleh, R.; Jackson, T.; King, A.; Lea, S.M.; Newman, J.; Stuart, D. Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: The structure of empty capsids of foot-and-mouth disease virus. J. Virol. 1997, 71, 9743–9752. [Google Scholar] [CrossRef] [Green Version]
- Fry, E.E.; Lea, S.M.; Jackson, T.; Newman, J.W.; Ellard, F.M.; Blakemore, W.E.; Abu-Ghazaleh, R.; Samuel, A.; King, A.M.; Stuart, D.I. The structure and function of a foot-and-mouth disease virus–oligosaccharide receptor complex. EMBO J. 1999, 18, 543–554. [Google Scholar] [CrossRef] [Green Version]
- Wang, X.; Jin, Y.; Fan, X. Construction and immunogenicity of DNA vaccine plasmid expressing VP1 and VP4 genes of foot-and-mouth disease virus. Chin. J. Biol. 2010, 23, 168–175. [Google Scholar]
- Filgueira, M.P.; Wigdorovitz, A.; Romera, A.; Zamorano, P.; Borca, M.; Sadir, A. Detection and characterization of functional T-cell epitopes on the structural proteins VP2, VP3, and VP4 of foot and mouth disease virus O1 campos. Virology 2000, 271, 234–239. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ma, M.X.; Jin, N.; Liu, H.J.; Zheng, M.; Yin, G.F.; Tian, M.Y.; Lu, H.; Shen, G.-S.; Zhu, G.Z.; Zhang, Y.J. Molecular design and immunogenicity of a multiple-epitope FMDV antigen and DNA vaccination. Chem. Res. Chin. Univ. 2008, 24, 69–74. [Google Scholar] [CrossRef]
- Van Lierop, M.J.; Nilsson, P.R.; Wagenaar, J.P.; Van Noort, J.M.; Campbell, J.D.; Glass, E.J.; Joosten, I.; Hensen, E.J. The influence of MHC polymorphism on the selection of T-cell determinants of FMDV in cattle. Immunology 1995, 84, 79. [Google Scholar] [PubMed]
- Mohamed, R.M.; Aosai, F.; Chen, M.; Mun, H.S.; Norose, K.; Belal, U.S.; Piao, L.X.; Yano, A. Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes. Vaccine 2003, 21, 2852–2861. [Google Scholar] [CrossRef]
- Wang, Y.; Zhang, S.; Wang, L.; Liu, X.; Zhang, E.; Li, N.; Gao, Y.; Zhang, Y.; Li, L.; Wang, J. Protein expression profile of mast cells in response to recombinant VP1-VP4 of foot-and-mouth disease virus. Sheng Wu Gong Cheng Xue Bao 2016, 32, 1194–1203. [Google Scholar]
- Horak, C.E.; Mendoza, A.; Vega-Valle, E.; Albaugh, M.; Graff-Cherry, C.; McDermott, W.G.; Hua, E.; Merino, M.J.; Steinberg, S.M.; Khanna, C.; et al. Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2. Cancer Res. 2007, 67, 11751–11759. [Google Scholar] [CrossRef] [Green Version]
- Lim, J.; Jang, G.; Kang, S.; Lee, G.; Nga, D.T.T.; Phuong, D.T.L.; Kim, H.; El-Rifai, W.; Ruley, H.E.; Jo, D. Cell-permeable NM23 blocks the maintenance and progression of established pulmonary metastasis. Cancer Res. 2011, 71, 7216–7225. [Google Scholar] [CrossRef] [Green Version]
- Mathieu, B.; Olivier, D.W.; Floria, L.; Dominique, W.; Renaud, P.; Nicolas, C.; Christèle, D.-M.; Sylvie, D.; Béatrice, N.R.; Philippe, B.; et al. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Cancer Res. 2010, 70, 7710–7722. [Google Scholar]
- Muñoz-Fontela, C.; Mandinova, A.; Aaronson, S.A.; Lee, S.W. Emerging roles of p53 and other tumour-suppressor genes in immune regulation. Nat. Rev. Immunol. 2016, 16, 741–750. [Google Scholar] [CrossRef] [Green Version]
- Muñoz-Fontela, C.; Macip, S.; Martínez-Sobrido, L.; Brown, L.; Ashour, J.; Garcia-Sastre, A.; Lee, S.W.; Aaronson, S.A. Transcriptional role of p53 in interferon-mediated antiviral immunity. J. Exp. Med. 2008, 205, 1929–1938. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Feng, H.H.; Zhu, Z.X.; Cao, W.J.; Yang, F.; Zhang, X.L.; Du, X.L.; Zhang, K.S.; Liu, X.T.; Zheng, H. Foot-and-mouth disease virus induces lysosomal degradation of NME1 to impair p53-regulated interferon-inducible antiviral genes expression. Cell Death Dis. 2018, 9, 885. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Reggiori, F.; Komatsu, M.; Finley, K.; Simonsen, A. Autophagy: More than a nonselective pathway. Int. J. Cell Biol. 2012, 2012, 219625. [Google Scholar] [CrossRef] [PubMed]
- Kraft, C.; Peter, M.; Hofmann, K. Selective autophagy: Ubiquitin-mediated recognition and beyond. Nat. Cell Biol. 2010, 12, 836–841. [Google Scholar] [CrossRef]
- Svenning, S.; Johansen, T. Selective autophagy. Essays Biochem. 2013, 55, 79–92. [Google Scholar] [CrossRef] [Green Version]
- Deretic, V.; Levine, B. Autophagy, immunity, and microbial adaptations. Cell Host Microbe 2009, 5, 527–549. [Google Scholar] [CrossRef] [Green Version]
- Shoji-Kawata, S.; Levine, B. Autophagy, antiviral immunity, and viral countermeasures. Biochim. Biophys. Acta 2009, 1793, 1478–1484. [Google Scholar] [CrossRef] [Green Version]
- Dong, X.; Levine, B. Autophagy and viruses: Adversaries or allies? J. Innate Immun. 2013, 5, 480–493. [Google Scholar] [CrossRef]
- Cottam, E.M.; Whelband, M.C.; Wileman, T. Coronavirus NSP6 restricts autophagosome expansion. Autophagy 2014, 10, 1426–1441. [Google Scholar] [CrossRef] [Green Version]
- Sun, M.X.; Huang, L.; Wang, R.; Yu, Y.L.; Li, C.; Li, P.P.; Hu, X.C.; Hao, H.P.; Ishag, H.A.; Mao, X. Porcine reproductive and respiratory syndrome virus induces autophagy to promote virus replication. Autophagy 2012, 8, 1434–1447. [Google Scholar] [CrossRef]
- Saiz, J.C.; Gonzalez, M.J.; Borca, M.V.; Sobrino, F.; Moore, D.M. Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. J. Virol. 1991, 65, 2518–2524. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mateu, M.G.; Hernández, J.; Martinez, M.A.; Feigelstock, D.; Lea, S.; Pérez, J.J.; Giralt, E.; Stuart, D.; Palma, E.L.; Domingo, E. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J. Virol. 1994, 68, 1407–1417. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Barnett, P.V.; Ouldridge, E.J.; Rowlands, D.J.; Brown, F.; Parry, N.R. Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. J. Virol. 1989, 70, 1483–1491. [Google Scholar] [CrossRef] [PubMed]
- Xue, M.; Wang, H.; Li, W.; Zhou, G.; Tu, Y.; Yu, L. Effects of amino acid substitutions in the VP2 B-C loop on antigenicity and pathogenicity of serotype Asia1 foot-and-mouth disease virus. J. Virol. 2012, 9, 191. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sun, P.; Zhang, S.; Qin, X.; Chang, X.; Cui, X.; Li, H.; Zhang, S.; Gao, H.; Wang, P.; Zhang, Z.; et al. Foot-and-mouth disease virus capsid protein VP2 activates the cellular EIF2S1-ATF4 pathway and induces autophagy via HSPB1. Autophagy 2018, 14, 336–346. [Google Scholar] [CrossRef] [PubMed]
- Chiramel, A.I.; Brady, N.R.; Bartenschlager, R. Divergent roles of autophagy in virus infection. Cells 2013, 2, 83–104. [Google Scholar] [CrossRef] [Green Version]
- Richetta, C.; Faure, M. Autophagy in antiviral innate immunity. Cell. Microbiol. 2013, 15, 368–376. [Google Scholar] [CrossRef]
- Rhea, S.; Beth, L. Autophagy and innate immunity: Triggering, targeting and tuning. Semin. Cell. Dev. Biol. 2010, 21, 699–711. [Google Scholar]
- Jounai, N.; Takeshita, F.; Kobiyama, K.; Sawano, A.; Miyawaki, A.; Xin, K.Q.; Ishii, K.J.; Kawai, T.; Akira, S.; Suzuki, K.; et al. The Atg5–Atg12 conjugate associates with innate antiviral immune responses. Proc. Natl. Acad. Sci. USA 2007, 104, 14050–14055. [Google Scholar] [CrossRef] [Green Version]
- Curry, S.; Fry, E.; Blakemore, W.; Ghazaleh, R.A.; Jackson, T.; King, A.; Lea, S.; Newman, J.; Rowlands, D.; Stuart, D. Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity. Structure 1996, 4, 135–145. [Google Scholar] [CrossRef] [Green Version]
- Biswal, J.K.; Mohapatra, J.K.; Bisht, P.; Subramaniam, S.; Sanyal, A.; Pattnaik, B. A positively charged lysine residue at VP2 131 position allows for the enhanced adaptability of foot-and-mouth disease virus serotype A in BHK-21 cells. Biologicals 2015, 43, 71–78. [Google Scholar] [CrossRef] [PubMed]
- Wang, H.; Song, S.; Zeng, J.; Zhou, G.; Yang, D.; Liang, T.; Yu, L. Single amino acid substitution of VP1 N17D or VP2 H145Y confers acid-resistant phenotype of type Asia1 foot-and-mouth disease virus. Virol. Sin. 2014, 29, 103–111. [Google Scholar] [CrossRef] [PubMed]
- Ganji, V.K.; Biswal, J.K.; Lalzampuia, H.; Basagoudanavar, S.H.; Saravanan, P.; Selvan, R.T.; Umapathi, V.; Reddy, G.R.; Sanyal, A.; Dechamma, H.J. Mutation in the VP2 gene of P1-2A capsid protein increases the thermostability of virus-like particles of foot-and-mouth disease virus serotype O. Appl. Microbiol. Biotechnol. 2018, 102, 8883–8893. [Google Scholar] [CrossRef] [PubMed]
- Choudary, S.; Ravikumar, P.; Kumar, C.A.; Suryanarayana, V.V.S.; Reddy, G.R. Enhanced immune response of DNA vaccine (VP1-pCDNA) adsorbed on cationic PLG for foot and mouth disease in guinea pigs. Virus Genes 2008, 37, 81–87. [Google Scholar] [CrossRef] [PubMed]
- Guzman, E.; Taylor, G.; Charleston, B.; Ellis, S.A. Induction of a cross-reactive CD8+ T cell response following foot-and-mouth disease virus vaccination. J. Virol. 2010, 84, 12375–12384. [Google Scholar] [CrossRef] [Green Version]
- Peng, J.M.; Liang, S.M.; Liang, C.M. VP1 of Foot-and-mouth disease virus induces apoptosis via the Akt signaling pathway. J. Biol. Chem. 2004, 279, 52168–52174. [Google Scholar] [CrossRef] [Green Version]
- Zhu, Z.; Li, W.; Zhang, X.; Wang, C.; Gao, L.; Yang, F.; Cao, W.; Li, K.; Tian, H.; Liu, X.; et al. Foot-and-mouth disease virus capsid protein VP1 interacts with host ribosomal protein SA to maintain activation of the MAPK signal pathway and promote virus replication. J. Virol. 2019, 94. [Google Scholar] [CrossRef] [Green Version]
- Li, D.; Yang, W.; Yang, F.; Liu, H.; Zhu, Z.; Lian, K.; Lei, C.; Li, S.; Liu, X.; Zheng, H.; et al. The VP3 structural protein of foot-and-mouth disease virus inhibits the IFN-β signaling pathway. FASEB J. 2016, 30, 1757–1766. [Google Scholar] [CrossRef] [Green Version]
- Li, D.; Wei, J.; Yang, F.; Liu, H.N.; Zhu, Z.X.; Cao, W.J.; Li, S.; Liu, X.T.; Zheng, H.; Shu, H.B. Foot-and-mouth disease virus structural protein VP3 degrades Janus kinase 1 to inhibit IFN-gamma signal transduction pathways. Cell Cycle 2016, 15, 850–860. [Google Scholar] [CrossRef] [Green Version]
- Qi, L.; Wang, K.; Chen, H.; Liu, X.; Lv, J.; Hou, S.; Zhang, Y.; Sun, Y. Host microRNA miR-1307 suppresses foot-and-mouth disease virus replication by promoting VP3 degradation and enhancing innate immune response. Virology 2019, 535, 162–170. [Google Scholar] [CrossRef]
- Li, D.; Yang, W.; Ren, J.; Ru, Y.; Zhang, K.; Fu, S.; Liu, X.; Zheng, H. The E3 ubiquitin ligase TBK1 mediates the degradation of multiple picornavirus VP3 proteins by phosphorylation and ubiquitination. J. Virol. 2019, 93, e01438-19. [Google Scholar] [CrossRef]
- Gutkoska, J.; Larocco, M.; Ramirez-Medina, E.; Santos, T.D.L.; Lawrence, P. Host microRNA-203a Is antagonistic to the progression of foot-and-mouth disease virus infection. Virology 2017, 504, 52–62. [Google Scholar] [CrossRef] [PubMed]
- Clarke, B.E.; Sangar, D.V.; Burroughs, J.N.; Newton, S.E.; Carroll, A.R.; Rowlands, D.J. Two initiation sites for foot-and-mouth disease virus polyprotein in vivo. J. Gen. Virol. 1985, 66, 2615–2626. [Google Scholar] [CrossRef] [PubMed]
- Medina, M.; Domingo, E.; Brangwyn, J.K.; Belsham, G.J. The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities. Virology 1993, 194, 355–359. [Google Scholar] [CrossRef]
- Roberts, P.J.; Belsham, G.J. Identification of critical amino acids within the foot-and-mouth disease virus leader protein, a cysteine protease. Virology 1995, 213, 140–146. [Google Scholar] [CrossRef] [PubMed]
- Gingras, A.C.; Raught, B.; Sonenberg, N. eIF4 initiation factors: Effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 1999, 68, 913–963. [Google Scholar] [CrossRef]
- Glaser, W.; Cencic, R.; Skern, T. Foot-and-mouth disease virus leader proteinase involvement of c-terminal residues in self-processing and cleavage of eIF4GI. J. Biol. Chem. 2001, 276, 35473–35481. [Google Scholar] [CrossRef] [Green Version]
- Belsham, G.J. Divergent picornavirus IRES elements. Virus Res. 2009, 139, 183–192. [Google Scholar] [CrossRef]
- Glaser, W.; Skern, T. Extremely efficient cleavage of eIF4G by picornaviral proteinases L and 2A in vitro. FEBS Lett. 2000, 480, 151–155. [Google Scholar] [CrossRef]
- Moral-López, P.; Alvarez, E.; Redondo, N.; Skern, T.; Carrasco, L. L protease from foot and mouth disease virus confers eIF2-independent translation for mRNAs bearing picornavirus IRES. FEBS Lett. 2014, 588, 4053–4059. [Google Scholar] [CrossRef] [Green Version]
- De Los Santos, T.; Diaz-San Segundo, F.; Grubman, M.J. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J. Virol. 2007, 81, 12803–12815. [Google Scholar] [CrossRef] [Green Version]
- Wang, D.; Fang, L.; Luo, R.; Ye, R.; Fang, Y.; Xie, L.; Chen, H.; Xiao, S. Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels. Biochem. Biophys. Res. Commun. 2010, 399, 72–78. [Google Scholar] [CrossRef]
- Wang, D.; Fang, L.; Liu, L.; Zhong, H.; Chen, Q.; Luo, R.; Liu, X.; Zhang, Z.; Chen, H.; Xiao, S. Foot-and-mouth disease virus (FMDV) leader proteinase negatively regulates the porcine interferon-λ1 pathway. Mol. Immunol. 2011, 49, 407–412. [Google Scholar] [CrossRef]
- Wang, D.; Fang, L.; Li, P.; Sun, L.; Fan, J.; Zhang, Q.; Luo, R.; Liu, X.; Li, K.; Chen, H.; et al. The leader proteinase of foot-and-mouth disease virus negatively regulates the type i interferon pathway by acting as a viral deubiquitinase. J. Virol. 2011, 85, 3758–3766. [Google Scholar] [CrossRef] [Green Version]
- Swatek, K.N.; Aumayr, M.; Pruneda, J.N.; Visser, L.J.; Berryman, S.; Kueck, A.F.; Geurink, P.P.; Ovaa, H.; Van Kuppeveld, F.J.M.; Tuthill, T.J.; et al. Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies. Proc. Natl. Acad. Sci. USA 2018, 115, 2371–2376. [Google Scholar] [CrossRef] [Green Version]
- Medina, G.N.; Azzinaro, P.; Ramirez-Medina, E.; Gutkoska, J.; Fang, Y.; Segundo, F.D.S.; Santos, T.D.L. Impairment of the DeISGylation activity of foot-and-mouth disease virus lpro causes attenuation in vitro and in vivo. J. Virol. 2020, 94. [Google Scholar] [CrossRef] [Green Version]
- Visser, L.J.; Aloise, C.; Swatek, K.N.; Medina, G.N.; Olek, K.M.; Rabouw, H.H.; De Groot, R.J.; Langereis, M.A.; Santos, T.D.L.; Komander, D.; et al. Dissecting distinct proteolytic activities of FMDV Lpro implicates cleavage and degradation of RLR signaling proteins, not its deISGylase/DUB activity, in type I interferon suppression. PLoS Pathog. 2020, 16, e1008702. [Google Scholar] [CrossRef]
- Bruns, A.M.; Horvath, C.M. LGP2 synergy with MDA5 in RLR-mediated RNA recognition and antiviral signaling. Cytokine 2015, 74, 198–206. [Google Scholar] [CrossRef] [Green Version]
- Liu, Y.; Qu, L.; Liu, Y.; Roizman, B.; Zhou, G.G. PUM1 is a biphasic negative regulator of innate immunity genes by suppressing LGP2. Proc. Natl. Acad. Sci. USA 2017, 114, E6902–E6911. [Google Scholar] [CrossRef] [Green Version]
- Rodríguez-Pulido, M.; Sánchez-Aparicio, M.T.; Martínez-Salas, E.; García-Sastre, A.; Sobrino, F.; Saiz, M. Innate immune sensor LGP2 is cleaved by the Leader protease of foot-and-mouth disease virus. PLoS Pathog. 2018, 14, e1007135. [Google Scholar] [CrossRef]
- Kedersha, N.; Ivanov, P.; Anderson, P.J. Stress granules and cell signaling: More than just a passing phase? Trends Biochem. Sci. 2013, 38, 494–506. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- McCormick, C.; Khaperskyy, D.A. Translation inhibition and stress granules in the antiviral immune response. Nat. Rev. Immunol. 2017, 17, 647–660. [Google Scholar] [CrossRef] [PubMed]
- Reineke, L.C.; Kedersha, N.; Langereis, M.A.; Van Kuppeveld, F.J.M.; Lloyd, R.E. Stress granules regulate double-stranded RNA-dependent protein kinase activation through a complex containing G3BP1 and caprin1. mBio 2015, 6, e02486-14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Reineke, L.C.; Lloyd, R.E. The stress granule protein G3BP1 recruits protein kinase R to promote multiple innate immune antiviral responses. J. Virol. 2014, 89, 2575–2589. [Google Scholar] [CrossRef] [Green Version]
- Visser, L.J.; Medina, G.N.; Rabouw, H.H.; De Groot, R.J.; Langereis, M.A.; Santos, T.D.L.; Van Kuppeveld, F.J.M. Foot-and-mouth disease virus leader protease cleaves G3BP1 and G3BP2 and inhibits stress granule formation. J. Virol. 2018, 93, e00922-18. [Google Scholar] [CrossRef] [Green Version]
- Ao, D.; Guo, H.C.; Sun, S.; Sun, D.H.; Fung, T.S.; Wei, Y.Q.; Han, S.C.; Yao, X.P.; Cao, S.Z.; Liu, D.X.; et al. Viroporin activity of the foot-and-mouth disease virus non-structural 2B protein. PLoS ONE 2015, 10, e0125828. [Google Scholar] [CrossRef] [Green Version]
- De Jong, A.S.; De Mattia, F.; Van Dommelen, M.M.; Lanke, K.; Melchers, W.J.G.; Willems, P.H.G.M.; Van Kuppeveld, F.J. Functional analysis of picornavirus 2B proteins: Effects on calcium homeostasis and intracellular protein trafficking. J. Virol. 2008, 82, 3782–3790. [Google Scholar] [CrossRef] [Green Version]
- Kato, H.; Takeuchi, O.; Sato, S.; Yoneyama, M.; Yamamoto, M.; Matsui, K.; Uematsu, S.; Jung, A.; Kawai, T.; Ishii, K.J.; et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441, 101–105. [Google Scholar] [CrossRef]
- Yoneyama, M.; Onomoto, K.; Jogi, M.; Akaboshi, T.; Fujita, T. Viral RNA detection by RIG-I-like receptors. Curr. Opin. Immunol. 2015, 32, 48–53. [Google Scholar] [CrossRef]
- Zhu, Z.; Wang, G.; Yang, F.; Cao, W.; Mao, R.; Du, X.; Zhang, X.; Li, C.; Li, D.; Zhang, K.; et al. Foot-and-mouth disease virus viroporin 2B antagonizes RIG-I-mediated antiviral effects by inhibition of its protein expression. J. Virol. 2016, 90, 11106–11121. [Google Scholar] [CrossRef] [Green Version]
- Zhu, Z.; Li, C.; Du, X.; Wang, G.; Cao, W.; Yang, F.; Feng, H.; Zhang, X.; Shi, Z.; Liu, H.; et al. Foot-and-mouth disease virus infection inhibits LGP2 protein expression to exaggerate inflammatory response and promote viral replication. Cell Death Dis. 2017, 8, e2747. [Google Scholar] [CrossRef] [Green Version]
- Li, M.; Xin, T.; Gao, X.; Wu, J.; Wang, X.; Fang, L.; Sui, X.; Zhu, H.; Cui, S.; Guo, X. Foot-and-mouth disease virus non-structural protein 2B negatively regulates the RLR-mediated IFN-β induction. Biochem. Biophys. Res. Commun. 2018, 504, 238–244. [Google Scholar] [CrossRef]
- Zhang, Z.; Pan, L.; Ding, Y.; Lv, J.; Zhou, P.; Fang, Y.; Liu, X.S.; Zhang, Y.G.; Wang, Y. eEF1G interaction with foot-and-mouth disease virus nonstructural protein 2B: Identification by yeast two-hybrid system. Microb. Pathog. 2017, 112, 111–116. [Google Scholar] [CrossRef]
- Ong, L.L.; Lin, P.C.; Zhang, X.; Chia, S.M.; Yu, H. Kinectin-dependent assembly of translation elongation factor-1 complex on endoplasmic reticulum regulates protein synthesis. J. Biol. Chem. 2006, 281, 33621–33634. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, H.; Xue, Q.; Cao, W.; Yang, F.; Ma, L.; Liu, W.; Zhang, K.; Liu, X.; Zhu, Z.; Zheng, H. Foot-and-mouth disease virus nonstructural protein 2B interacts with cyclophilin A, modulating virus replication. FASEB J. 2018, 32, 6706–6723. [Google Scholar] [CrossRef] [PubMed]
- Liu, W.; Li, J.; Zheng, W.; Shang, Y.; Zhao, Z.; Wang, S.; Bi, Y.; Zhang, S.; Xu, C.; Duan, Z.; et al. Cyclophilin A-regulated ubiquitination is critical for RIG-I-mediated antiviral immune responses. eLife 2017, 6, 24425. [Google Scholar] [CrossRef] [PubMed]
- Klein, M.; Zimmermann, H.; Nelsen-Salz, B.; Hadaschik, D.; Eggers, H.J. The picornavirus replication inhibitors HBB and guanidine in the echovirus-9 system: The significance of viral protein 2C. J. Gen. Virol. 2000, 81, 895–901. [Google Scholar] [CrossRef] [PubMed]
- Teterina, N.L.; Gorbalenya, A.E.; Egger, D.; Bienz, K.; Rinaudo, M.S.; Ehrenfeld, E. Testing the modularity of the N-terminal amphipathic helix conserved in picornavirus 2C proteins and hepatitis C NS5A protein. Virology 2006, 344, 453–467. [Google Scholar] [CrossRef] [PubMed]
- Saunders, K.; King, A.M. Guanidine-resistant mutants of aphthovirus induce the synthesis of an altered nonstructural polypeptide, P34. J. Virol. 1982, 42, 389–394. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Saunders, K.; King, A.M.; McCahon, D.; Newman, J.W.; Slade, W.R.; Forss, S. Recombination and oligonucleotide analysis of guanidine-resistant foot-and-mouth disease virus mutants. J. Virol. 1985, 56, 921–929. [Google Scholar] [CrossRef] [Green Version]
- Gannagé, M.; Rämer, P.C.; Münz, C. Targeting Beclin 1 for viral subversion of macroautophagy. Autophagy 2010, 6, 166–167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kang, R.; Zeh, H.J.; Lotze, M.T.; Tang, D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011, 18, 571–580. [Google Scholar] [CrossRef] [PubMed]
- Gladue, D.P.; O’Donnell, V.; Baker-Branstetter, R.; Holinka, L.G.; Pacheco, J.M.; Fernandez-Sainz, I.; Lu, Z.; Brocchi, E.; Baxt, B.; Piccone, M.E.; et al. Foot-and-mouth disease virus nonstructural protein 2C interacts with beclin1, modulating virus replication. J. Virol. 2012, 86, 12080–12090. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Earl, R.T.; Mangiapane, E.H.; Billett, E.E.; Mayer, R.J. A putative protein-sequestration site involving intermediate filaments for protein degradation by autophagy. Studies with transplanted Sendai-viral envelope proteins in HTC cells. Biochem. J. 1987, 241, 809–815. [Google Scholar] [CrossRef] [PubMed]
- Mayer, R.J.; Gaskell, M.J.; Earl, R.; Billett, E.E.; Mangiapane, H.E.; Fernig, D.; Doherty, F.J. Intracellular protein catabolism: Evidence for sequestration of proteins into an intermediate-filament fraction before lysosomal degradation. Biomed. Biochim. Acta 1986, 45, 1591–1602. [Google Scholar]
- Gladue, D.P.; O’Donnell, V.; Baker-Branstetter, R.; Holinka, L.G.; Pacheco, J.M.; Sainz, I.F.; Lu, Z.; Ambroggio, X.; Rodríguez, L.; Borca, M. Foot-and-mouth disease virus modulates cellular vimentin for virus survival. J. Virol. 2013, 87, 6794–6803. [Google Scholar] [CrossRef] [Green Version]
- Pacheco, J.M.; Henry, T.M.; O’Donnell, V.K.; Gregory, J.B.; Mason, P.W. Role of nonstructural proteins 3A and 3B in host rangeand pathogenicity of foot-and-mouth diseasevirus. J. Virol. 2003, 77, 13017–13027. [Google Scholar] [CrossRef] [Green Version]
- Rosas, M.F.; Vieira, Y.A.; Postigo, R.; Martín-Acebes, M.A.; Armas-Portela, R.; Martínez-Salas, E.; Sobrino, F.; Martínez-Salas, E. Susceptibility to viral infection is enhanced by stable expression of 3A or 3AB proteins from foot-and-mouth disease virus. Virology 2008, 380, 34–45. [Google Scholar] [CrossRef] [Green Version]
- Gladue, D.P.; O’Donnell, V.; Baker-Bransetter, R.; Pacheco, J.M.; Holinka, L.G.; Arzt, J.; Pauszek, S.; Fernandez-Sainz, I.; Fletcher, P.; Brocchi, E.; et al. Interaction of foot-and-mouth disease virus nonstructural protein 3A with host protein DCTN3 is important for viral virulence in cattle. J. Virol. 2013, 88, 2737–2747. [Google Scholar] [CrossRef] [Green Version]
- Pacheco, J.M.; Gladue, D.P.; Holinka, L.G.; Arzt, J.; Bishop, E.; Smoliga, G.; Pauszek, S.J.; Bracht, A.J.; O’Donnell, V.; Fernandez-Sainz, I.; et al. A partial deletion in non-structural protein 3A can attenuate foot-and-mouth disease virus in cattle. Virology 2013, 446, 260–267. [Google Scholar] [CrossRef] [Green Version]
- Pacheco, J.M.; Mason, P.W. Evaluation of infectivity and transmission of different Asian foot-and-mouth disease viruses in swine. J. Veter. Sci. 2010, 11, 133–142. [Google Scholar] [CrossRef] [Green Version]
- Li, D.; Lei, C.; Xu, Z.; Yang, F.; Liu, H.; Zhu, Z.; Li, S.; Liu, X.; Shu, H.B.; Zheng, H. Foot-and-mouth disease virus non-structural protein 3A inhibits the interferon-β signaling pathway. Sci. Rep. 2016, 6, 21888. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Carrillo, C.; Tulman, E.R.; Delhon, G.; Lu, Z.; Carreño, A.; Vagnozzi, A.; Kutish, G.F.; Rock, D.L. Comparative genomics of foot-and-mouth disease virus. J. Virol. 2005, 79, 6487–6504. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Falk, M.M.; Sobrino, F.; Beck, E. VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus. J. Virol. 1992, 66, 2251–2260. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pacheco, J.M.; Piccone, M.E.; Rieder, E.; Pauszek, S.; Borca, M.; Rodriguez, L.L. Domain disruptions of individual 3B proteins of foot-and-mouth disease virus do not alter growth in cell culture or virulence in cattle. Virology 2010, 405, 149–156. [Google Scholar] [CrossRef] [Green Version]
- Zhang, X.; Wang, C.; Yang, F.; Cao, W.; Li, P.; Du, X.; Liu, X.; Zhu, Z.; Zheng, H. Foot-and-mouth disease virus 3B protein inhibits type I interferon pathway signaling by blocking the interaction of RIG-I with TRIM25. In Proceedings of the 17th International Congress of Immunology, Beijing, China, 19 October 2019; p. 1. [Google Scholar]
- Falk, M.M.; Grigera, P.R.; Bergmann, I.E.; Zibert, A.; Multhaup, G.; Beck, E. Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. J. Virol. 1990, 64, 748–756. [Google Scholar] [CrossRef] [Green Version]
- Belsham, G.J.; McInerney, G.M.; Ross-Smith, N. Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells. J. Virol. 2000, 74, 272–280. [Google Scholar] [CrossRef] [Green Version]
- Li, W.; Ross-Smith, N.; Proud, C.; Belsham, G.J. Cleavage of translation initiation factor 4AI (eIF4AI) but not eIF4AII by foot-and-mouth disease virus 3C protease: Identification of the eIF4AI cleavage site. FEBS Lett. 2001, 507, 1–5. [Google Scholar] [CrossRef]
- Strong, R.; Belsham, G.J. Sequential modification of translation initiation factor eIF4GI by two different foot-and-mouth disease virus proteases within infected baby hamster kidney cells: Identification of the 3Cpro cleavage site. J. Gen. Virol. 2004, 85, 2953–2962. [Google Scholar] [CrossRef]
- Pause, A.; Méthot, N.; Svitkin, Y.; Merrick, W.; Sonenberg, N. Dominant negative mutants of mammalian translation initiation factor eIF-4A define a critical role for eIF-4F in cap-dependent and cap-independent initiation of translation. EMBO J. 1994, 13, 1205–1215. [Google Scholar] [CrossRef]
- Lawrence, P.; Schafer, E.A.; Rieder, E. The nuclear protein Sam68 is cleaved by the FMDV 3C protease redistributing Sam68 to the cytoplasm during FMDV infection of host cells. Virology 2012, 425, 40–52. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, D.; Fang, L.; Li, K.; Zhong, H.; Fan, J.; Ouyang, C.; Zhang, H.; Duan, E.; Luo, R.; Zhang, Z.; et al. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling. J. Virol. 2012, 86, 9311–9322. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Du, Y.; Bi, J.; Liu, J.; Liu, X.; Wu, X.; Jiang, P.; Yoo, D.; Zhang, Y.; Wu, J.; Wan, R.; et al. 3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation. J. Virol. 2014, 88, 4908–4920. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fan, X.; Han, S.; Yan, D.; Gao, Y.; Wei, Y.; Liu, X.; Liao, Y.; Guo, H.; Sun, S. Foot-and-mouth disease virus infection suppresses autophagy and NF-kB antiviral responses via degradation of ATG5-ATG12 by 3Cpro. Cell Death Dis. 2017, 8, e2561. [Google Scholar] [CrossRef]
- Nallagatla, S.R.; Toroney, R.; Bevilacqua, P.C. Regulation of innate immunity through RNA structure and the protein kinase PKR. Curr. Opin. Struct. Biol. 2011, 21, 119–127. [Google Scholar] [CrossRef] [Green Version]
- Li, C.; Zhu, Z.; Du, X.; Cao, W.; Yang, F.; Zhang, X.; Feng, H.; Li, D.; Zhang, K.; Liu, X.; et al. Foot-and-mouth disease virus induces lysosomal degradation of host protein kinase PKR by 3C proteinase to facilitate virus replication. Virology 2017, 509, 222–231. [Google Scholar] [CrossRef]
- Gao, Y.; Sun, S.; Guo, H. Biological function of Foot-and-mouth disease virus non-structural proteins and non-coding elements. J. Virol. 2016, 13, 107. [Google Scholar] [CrossRef] [Green Version]
- Kloc, A.; Segundo, F.D.S.; Schafer, E.; Rai, D.K.; Kenney, M.; Santos, T.D.L.; Rieder, E. Foot-and-mouth disease virus 5′-terminal S fragment is required for replication and modulation of the innate immune response in host cells. Virology 2017, 512, 132–143. [Google Scholar] [CrossRef]
- Zibert, A.; Maass, G.; Strebel, K.; Falk, M.M.; Beck, E. Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA. J. Virol. 1990, 64, 2467–2473. [Google Scholar] [CrossRef] [Green Version]
- Zhu, Z.; Yang, F.; Cao, W.; Liu, H.; Zhang, K.; Tian, H.; Dang, W.; He, J.; Guo, J.; Liu, X.; et al. The Pseudoknot region of the 5′ untranslated region is a determinant of viral tropism and virulence of foot-and-mouth disease virus. J. Virol. 2019, 93. [Google Scholar] [CrossRef] [Green Version]
- McKnight, K.L.; Lemon, S.M. The rhinovirus type 14 genome contains an internally located RNA structure that is required for viral replication. RNA 1998, 4, 1569–1584. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Paul, A.V.; Rieder, E.; Kim, D.W.; Van Boom, J.H.; Wimmer, E. Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J. Virol. 2000, 74, 10359–10370. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mason, P.W.; Bezborodova, S.V.; Henry, T.M. Identification and characterization of a cis-acting replication element (cre) adjacent to the internal ribosome entry site of foot-and-mouth disease virus. J. Virol. 2002, 76, 9686–9694. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Belsham, G.J. Translation and replication of FMDV RNA. Curr. Top. Microbiol. Immunol. 2005, 288, 43–70. [Google Scholar]
- Serrano, P.; Rodríguez-Pulido, M.; Saiz, M.; Martínez-Salas, E. The 3′ end of the foot-and-mouth disease virus genome establishes two distinct long-range RNA-RNA interactions with the 5′ end region. J. Gen. Virol. 2006, 87, 3013–3022. [Google Scholar] [CrossRef]
- García-Nuñez, S.; Gismondi, M.I.; König, G.; Berinstein, A.; Taboga, O.; Rieder, E.; Martínez-Salas, E.; Carrillo, E.; Martínez-Salas, E. Enhanced IRES activity by the 3′UTR element determines the virulence of FMDV isolates. Virology 2014, 448, 303–313. [Google Scholar] [CrossRef] [Green Version]
- Saiz, M.; Gomez, S.; Martinez-Salas, E.; Sobrino, F. Deletion or substitution of the aphthovirus 3′ NCR abrogates infectivity and virus replication. J. Gen. Virol. 2001, 82, 93–101. [Google Scholar] [CrossRef]
- Stenfeldt, C.; Segundo, F.D.-S.; Santos, T.D.L.; Rodriguez, L.L.; Arzt, J. The pathogenesis of foot-and-mouth disease in pigs. Front. Veter. Sci. 2016, 3, 12. [Google Scholar] [CrossRef]
- Stenfeldt, C.; Pacheco, J.M.; Borca, M.; Rodriguez, L.L.; Arzt, J. Morphologic and phenotypic characteristics of myocarditis in two pigs infected by foot-and mouth disease virus strains of serotypes O or A. Acta Veter. Scand. 2014, 56, 42. [Google Scholar] [CrossRef]
- Sei, J.J.; Waters, R.A.; Kenney, M.; Barlow, J.W.; Golde, W.T. Effect of foot-and-mouth disease virus infection on the frequency, phenotype and function of circulating dendritic cells in cattle. PLoS ONE 2016, 11, e0152192. [Google Scholar] [CrossRef]
- Nfon, C.K.; Toka, F.N.; Kenney, M.; Pacheco, J.M.; Golde, W.T. Loss of plasmacytoid dendritic cell function coincides with lymphopenia and viremia during foot-and-mouth disease virus infection. Viral Immunol. 2010, 23, 29–41. [Google Scholar] [CrossRef] [PubMed]
- Toka, F.N.; Nfon, C.; Dawson, H.; Golde, W.T. Natural killer cell dysfunction during acute infection with foot-and-mouth disease virus. Clin. Vaccine Immunol. 2009, 16, 1738–1749. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Toka, F.N.; Golde, W.T. Cell mediated innate responses of cattle and swine are diverse during foot-and-mouth disease virus (FMDV) infection: A unique landscape of innate immunity. Immunol. Lett. 2013, 152, 135–143. [Google Scholar] [CrossRef] [PubMed]
- Hull, C.M.; Bevilacqua, P.C. Discriminating self and non-self by RNA: Roles for RNA structure, misfolding, and modification in regulating the innate immune sensor PKR. Acc. Chem. Res. 2016, 49, 1242–1249. [Google Scholar] [CrossRef] [PubMed] [Green Version]
FMDV Protein | Cellular Proteins | Function of Cellular Proteins | Immune Escape |
---|---|---|---|
VP0 | IRF3 | Interferon regulatory factor 3 | VP0 protein inhibit the activation of type I interferon signal pathway by interacting with IRF3 [18]. |
PCBP2 | Poly (rC) binding protein 2 | VP0 proteins interacts with PCBP2 to promote the replication of FMDV [19]. | |
VP4 | NME1 | Nucleoside diphosphate kinase 1 | NME1 can be degraded by VP4 through macroautophagy pathway to perform antivirus function [34]. |
VP2 | HSPB1 | Heat shock protein family B [small] member 1 | Interaction between VP2 and HSPB1 activates the EIF2S1-ATF4 pathway, which leads to autophagy and promotes virus replication [47]. |
VP1 | Sorcin | Soluble resistance-related calcium binding protein | VP1 can bind to Sorcin to inhibit the activation of IKK and NF- κ B pathway [12]. |
TPL2 | Tumor progression locus 2; A serine/threonine protein kinase | VP1 inhibits the protein expression of TPL2 phosphorylation site Thr290, thereby inhibiting the promotion of IRF3-activated IFN- β signal by TPL2. | |
IRF3 | Interferon regulatory factor 3 | VP1 suppresses IFN-β signaling pathway at IRF3 level by inhibiting IRF3 phosphorylation, dimerization, and nuclear translocation. | |
RPSA | Ribosomal protein SA | VP1 interacts with RPSA to maintain the activation of MAPK signal pathway and promote virus replication [59]. | |
VP3 | VISA | Innate immune junction molecule | VP3 inhibits the expression of VISA protein mRNA, and interacts with VISA protein to inhibit the formation of VISA-regulated complex, thereby inhibiting the dimerization and phosphorylation of IRF3 [60]. |
JAK1 | Janus kinase 1 | VP3 can interact with JAK1 protein and degrade JAK1 protein to inhibit the activation of JAK-STAT pathway [61]. |
FMDV Protein | Cellular Proteins | Function of Cellular Proteins | Immune Escape |
---|---|---|---|
Lpro | eIF4G | eukaryotic initiation factor 4G | Lpro cut eIF4GI and eIF4GII, thus preventing the recruitment of capped mRNA and inhibiting the synthesis of antiviral molecules [68,69]. |
NF-κB | Nuclear factor kappa B | Lpro induce the degradation of p65/RelA, which is the core component of NF-κB [73]. | |
IRF3/7 | Interferon regulatory factor 3/7 | Lpro decreased the expression of IRF3/7 to inhibit the production of type I IFN induced by dsRNA [74]. | |
RIG-I TBK1 TRAF6 TRAF3 | Retinoic acid inducible gene I; TANK binding kinase I; TNF receptor associated factor 6 TNF receptor associated factor 3 | Lpro can significantly inhibit the ubiquitination of key molecules of innate immune signaling pathway such as RIG-I, TBK1, TRAF6, and TRAF3 [76]. | |
ADNP | Activity dependent neuroprotective protein | Lpro and ADNP interact to promote the replication of FMDV by inhibiting the expression of IFN and ISG [13]. | |
LGP2 | Laboratory of Genetics and Physiology2 | Lpro can cleave LGP2 and block the effect of LGP2-mediated the production of IFN-β [82]. | |
G3BP1 and G3BP2 | stress granule scaffold proteins | Lpro targets to cleave the SG scaffold proteins G3BP1 and G3BP2 to antagonize the formation of SG [87]. | |
2B | RIG-I, MDA5 and LGP2 | Retinoic acid inducible gene I; melanoma differentiation associated factor 5; Laboratory of Genetics and Physiology 2; | 2B protein suppress the expression of RIG-I, MDA5 and LGP2, inhibiting host antiviral response [93,94]. |
TBK1; IRF3 | TANK binding kinase I; Interferon regulatory factor 3 | 2B suppress the phosphorylation of TBK1 and IRF3, and then inhibit the expression of type I interferon [93]. | |
CypA | cyclophilin A | the interaction between 2B protein and cyclophilin A directly inhibits the degradation of Lpro and 3A protein by cyclophilin A [97]. | |
NOD2 | nucleotide-binding oligomerization domain 2 | 2B protein can interact with NOD2 to reduce the protein level of NOD2, which inhibit the activation of NF- κB and IFN- β signal pathways [16]. | |
2C | Beclin1 | involve in the fusion of autophagosomes to lysosomes | 2C interacts with Beclin1 to induce Beclin1 inactivation, which inhibits the fusion of autophagosomes of containing FMDV and lysosomes [105]. |
NOD2 | nucleotide-binding oligomerization domain 2 | The interaction between FMDV protein 2C and NOD2 reduces NOD2 at the protein level to help the virus evade immune response [16]. | |
3A | DCTN3 | dynactin 3; a subunit of the dynactin complex | 3A-DCTN3 interaction may play a part in the virulence of bovine virus [111]. |
RIG-I, MDA5 and VISA | innate immune molecules | 3A protein interacted with RIG-I, MDA5 and VISA, to inhibited the expression of RIG-I, MDA5 and VISA protein mRNA [114]. | |
DDX56 | DEAD-Box Helicase 56 | 3A protein increases the interaction between DDX56 to inhibits the activation of IFN- β promoter and ISRE by reducing the phosphorylation of IRF3 [14]. | |
3B | RIG-I and TRIM25 | Retinoic acid inducible gene I; | 3B blocked the interaction between RIG-I and TRIM25, thus inhibiting the interferon signal pathway [118]. |
VISA | Virus-induced signaling adapter | 3B reduces the expression of type I interferon by inhibiting VISA signal pathway by interacting with VISA protein. | |
3C | Histone H3 | Related to the transcription of host cells | The cleavage of 3Cpro to H3 inhibits the transcription of host cells and ultimately hinders the translation of host cells [119]. |
eIF4G and eIF4A | Host translation initiation factors | 3Cpro is involved in the cleavage of eIF4G and eIF4A, thus inhibiting the synthesis of host-related antiviral proteins [120]. | |
Sam68 | 68 kDa Src-associated substrate during mitosis | 3Cpro can also cleave Sam68. Truncated Sam68 spreads to the cytoplasm and meets the FMDV RNA and attaches to the IRES to enhance the translation of the virus RNA [124]. | |
RIG-I and LGP2 | Retinoic acid inducible gene I; Laboratory of Genetics and Physiology 2; | protein 3Cpro can degrade RIG-I and LGP2 [92,93]. | |
NEMO | NF-κB necessary regulator | 3C can also degrade NEMO to impaired activation of IRFs and NF-κB [125]. | |
KPNA1 | the nuclear localization signal receptor for tyrosine-phosphorylated STAT1 | 3C promoted the degradation of KPNA1 to block the nuclear translocation of STAT1/STAT2 to inhibit JAK-STAT signal pathway [126]. | |
ATG5-ATG12 | Autophagy associated protein | FMDV protein 3Cpro antagonizes host antiviral immunity and suppresses autophagy by degrading ATG5-ATG12 [127]. | |
PKR | a serine-threonine kinase | 3Cpro induces PKR degradation and inhibits PKR-mediated antiviral effect by down-regulating PKR protein [129]. | |
NOD2 | nucleotide-binding oligomerization domain 2 | 3Cpro induces the reduction of NOD2, thus inhibiting the antiviral effect induced by NOD2 [16]. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yang, B.; Zhang, X.; Zhang, D.; Hou, J.; Xu, G.; Sheng, C.; Choudhury, S.M.; Zhu, Z.; Li, D.; Zhang, K.; et al. Molecular Mechanisms of Immune Escape for Foot-and-Mouth Disease Virus. Pathogens 2020, 9, 729. https://doi.org/10.3390/pathogens9090729
Yang B, Zhang X, Zhang D, Hou J, Xu G, Sheng C, Choudhury SM, Zhu Z, Li D, Zhang K, et al. Molecular Mechanisms of Immune Escape for Foot-and-Mouth Disease Virus. Pathogens. 2020; 9(9):729. https://doi.org/10.3390/pathogens9090729
Chicago/Turabian StyleYang, Bo, Xiaohui Zhang, Dajun Zhang, Jing Hou, GuoWei Xu, Chaochao Sheng, Sk Mohiuddin Choudhury, Zixiang Zhu, Dan Li, Keshan Zhang, and et al. 2020. "Molecular Mechanisms of Immune Escape for Foot-and-Mouth Disease Virus" Pathogens 9, no. 9: 729. https://doi.org/10.3390/pathogens9090729